[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614284":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":51,"collaborators":53,"id":57,"slug":25,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":58,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":78,"overallStatus":80,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Treatment","ACTIVE_COMPARATOR","Active treatment with kTMP for 18 weeks",[13],"Device: kTMP 18 weeks",{"label":15,"type":6,"description":16,"interventionNames":17},"Crossover Treatment","Initial 9 weeks will receive sham kTMP treatment, followed by 9 weeks of active kTMP treatment.",[18],"Device: kTMP sham stimulation 9 weeks + active stimulation 9 weeks",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","kTMP sham stimulation 9 weeks + active stimulation 9 weeks","kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation",[15],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"kTMP 18 weeks","Participants receive kTMP active stimulation for 18 weeks",[9],[31],{"name":32,"affiliation":5,"role":33},"Karunesh Ganguly, MD, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","415-514-1252","karunesh.ganguly@ucsf.edu",[40],{"facility":5,"status":25,"city":41,"state":42,"zip":43,"country":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":25},"San Francisco","California","94158","United States",{"type":46,"coordinates":47},"Point",[48,49],-122.41942,37.77493,{"lat":49,"lon":48},{"type":52,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[54],{"name":55,"class":56},"National Institute of Neurological Disorders and Stroke (NINDS)","NIH","100614284",false,"NCT07277595","kTMP in Chronic Stroke","KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.","KULMINATE","Inclusion Criteria:\n\n* Adults age 18-80 years old who have had a stroke resulting in hemiplegia\n* Ability to communicate, understand, and give appropriate consent\n* Other criteria may apply\n\nExclusion Criteria:\n\n* Significant cognitive impairment\n* inability to adhere to the study protocol or provide informed consent\n* pregnancy\n* additional criteria may apply","ALL","18 Years","80 Years",{"count":68,"type":69},100,"ESTIMATED","INTERVENTIONAL",[72],"NA","kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm\u002Fhand rehabilitation in patients who have been disabled by stroke.",[75,76,77],"Stroke","Chronic Stroke Patients","Arm Weakness as a Consequence of Stroke",[79],"transcranial magnetic stimulation","NOT_YET_RECRUITING","2026-05-01",{"date":83,"type":84},"2026-05-06","ACTUAL",{"date":86,"type":69},"2026-07-01",{"date":88,"type":69},"2030-08-01",{"name":5,"class":6},1]